| [1] |
Gong Y, Fu Z, Liegl R, Chen J, Hellström A, et al. 2017. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. |
| [2] |
Fu Z, Smith LEH. 2021. Cellular senescence in pathologic retinal angiogenesis. |
| [3] |
Galindo-Cabello N, Caballano-Infantes E, Benites G, Pastor-Idoate S, Diaz-Corrales FJ, et al. 2025. Retinal organoids: innovative tools for understanding retinal degeneration. |
| [4] |
Revokatova D, Bikmulina P, Heydari Z, Solovieva A, Vosough M, et al. 2025. Getting blood out of a stone: vascularization via spheroids and organoids in 3D bioprinting. |
| [5] |
González-Sastre R, Coronel R, Bernabeu-Zornoza A, Mateos-Martínez P, Rosca A, et al. 2024. Efficient generation of human cerebral organoids directly from adherent cultures of pluripotent stem cells. |
| [6] |
Bas-Cristóbal Menéndez A, Du Z, van den Bosch TPP, Othman A, Gaio N, et al. 2022. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system. |
| [7] |
Shin YJ, Safina D, Zheng Y, Levenberg S. 2025. Microvascularization in 3D human engineered tissue and organoids. |
| [8] |
Nguyen J, Lin YY, Gerecht S. 2021. The next generation of endothelial differentiation: Tissue-specific ECs. |
| [9] |
Xia J, Liu ZY, Han ZY, Yuan Y, Shao Y, et al. 2022. Regulation of cell attachment, spreading, and migration by hydrogel substrates with independently tunable mesh size. |
| [10] |
Wang K, Lin RZ, Hong X, Ng AH, Lee CN, et al. 2020. Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. |
| [11] |
Palikuqi B, Nguyen DT, Li G, Schreiner R, Pellegata AF, et al. 2020. Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis. |
| [12] |
Vargas-Valderrama A, Messina A, Mitjavila-Garcia MT, Guenou H. 2020. The endothelium, a key actor in organ development and hPSC-derived organoid vascularization. |
| [13] |
Ahn Y, An JH, Yang HJ, Lee DG, Kim J, et al. 2021. Human blood vessel organoids penetrate human cerebral organoids and form a vessel-like system. |
| [14] |
Sang X, Xu J, Wang Y, Li J, Xu J, et al. 2024. Generation of vascularized pancreatic progenitors through co-differentiation of endoderm and mesoderm from human pluripotent stem cells. |
| [15] |
Kang D, Hong G, An S, Jang I, Yun WS, et al. 2020. Bioprinting of multiscaled hepatic lobules within a highly vascularized construct. |
| [16] |
Li H, Shadrin I, Helfer A, Heman K, Rao L, et al. 2026. In vitro vascularization improves in vivo functionality of human engineered cardiac tissues. |
| [17] |
Nwokoye PN, Abilez OJ. 2024. Bioengineering methods for vascularizing organoids. |
| [18] |
Xing F, Xiang Z, Rommens PM, Ritz U. 2020. 3D bioprinting for vascularized tissue-engineered bone fabrication. |
| [19] |
Tamo AK, Tran TA, Doench I, Jahangir S, Lall A, et al. 2022. 3D printing of cellulase-laden cellulose nanofiber/chitosan hydrogel composites: towards tissue engineering functional biomaterials with enzyme-mediated biodegradation. |
| [20] |
Gudapati H, Dey M, Ozbolat I. 2016. A comprehensive review on droplet-based bioprinting: Past, present and future. |
| [21] |
You S, Xiang Y, Hwang HH, Berry DB, Kiratitanaporn W, et al. 2023. High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues. |
| [22] |
Li W, Mille LS, Robledo JA, Uribe T, Huerta V, et al. 2020. Recent advances in formulating and processing biomaterial inks for vat polymerization-based 3D printing. |
| [23] |
Abukunna FE, Aladdad AM, McLoughlin KJ, Thallapureddy K, Vierra M, et al. 2025. Three-dimensional bioprinting of astrocytes and endothelial cells to direct retinal axon growth and vascularization. |
| [24] |
Zheng F, Derby B, Wong J. 2021. Fabrication of microvascular constructs using high resolution electrohydrodynamic inkjet printing. |
| [25] |
Rayner SG, Howard CC, Mandrycky CJ, Stamenkovic S, Himmelfarb J, et al. 2021. Multiphoton-guided creation of complex organ-specific microvasculature. |
| [26] |
Bernal PN, Bouwmeester M, Madrid-Wolff J, Falandt M, Florczak S, et al. 2022. Volumetric bioprinting of organoids and optically tuned hydrogels to build liver-like metabolic biofactories. |
| [27] |
Duong VT, Lin CC. 2023. Digital light processing 3D bioprinting of gelatin-norbornene hydrogel for enhanced vascularization. |
| [28] |
Skylar-Scott MA, Uzel SGM, Nam LL, Ahrens JH, Truby RL, et al. 2019. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels. |
| [29] |
Wu KY, Osman RM, Esomchukwu O, Marchand M, Nguyen BH, et al. 2025. Advances in regenerative medicine, cell therapy, and 3D bioprinting for glaucoma and retinal diseases. In Cell Biology and Translational Medicine, ed. Turksen K. Vol. 25. Cham: Springer. pp.115−139 doi: 10.1007/5584_2025_854 |
| [30] |
Yin H, Wang Y, Liu N, Zhong S, Li L, et al. 2024. Advances in the model structure of in vitro vascularized organ-on-a-chip. |
| [31] |
Liu Y, Lin L, Qiao L. 2023. Recent developments in organ-on-a-chip technology for cardiovascular disease research. |
| [32] |
Seiler KM, Bajinting A, Alvarado DM, Traore MA, Binkley MM, et al. 2020. Patient-derived small intestinal myofibroblasts direct perfused, physiologically responsive capillary development in a microfluidic Gut-on-a-Chip Model. |
| [33] |
Rayner SG, Phong KT, Xue J, Lih D, Shankland SJ, et al. 2018. Reconstructing the human renal vascular–tubular unit in vitro. |
| [34] |
Akinbote A, Beltran-Sastre V, Cherubini M, Visone R, Hajal C, et al. 2021. Classical and non-classical fibrosis phenotypes are revealed by lung and cardiac like microvascular tissues on-chip. |
| [35] |
Liu J, Feng C, Zhang M, Song F, Liu H. 2022. Design and fabrication of a liver-on-a-chip reconstructing tissue-tissue interfaces. |
| [36] |
Hospodiuk-Karwowski M, Chi K, Pritchard J, Catchmark JM. 2022. Vascularized pancreas-on-a-chip device produced using a printable simulated extracellular matrix. |
| [37] |
Thomas BB, Rajendran Nair DS, Rahimian M, Hassan AK, Tran TL, et al. 2025. Animal models for the evaluation of retinal stem cell therapies. |
| [38] |
Kawai K, Ho MT, Ueno Y, Abdo D, Xue C, et al. 2024. Hyaluronan improves photoreceptor differentiation and maturation in human retinal organoids. |
| [39] |
Zhong X, Gutierrez C, Xue T, Hampton C, Vergara MN, et al. 2014. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. |
| [40] |
Chen H, Liang Y, Sun X, Xiong W, Yang T, et al. 2025. Generation of vascularized retinal organoids containing microglia based on a PDMS microwell platform. |
| [41] |
Xue Y, Seiler MJ, Tang WC, Wang JY, Delgado J, et al. 2021. Retinal organoids on-a-chip: a micro-millifluidic bioreactor for long-term organoid maintenance. |
| [42] |
Inagaki S, Nakamura S, Kuse Y, Aoshima K, et al. 2025. Establishment of vascularized human retinal organoids from induced pluripotent stem cells. |
| [43] |
Chen KY, Chan HC, Chan CM. 2025. Can stem cell therapy revolutionize ocular disease treatment? a critical review of preclinical and clinical advances. |
| [44] |
Kurzawa-Akanbi M, Tzoumas N, Corral-Serrano JC, Guarascio R, Steel DH, et al. 2024. Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity. |
| [45] |
Kim D, Yi S, Park BU, Lee SJ, Lee J, et al. 2025. Ready-to-use nanofiber membrane-integrated organ-on-a-chip via cryopreservation of cell-loaded microfluidic chip. |
| [46] |
Paek J, Park SE, Lu Q, Park KT, Cho M, et al. 2019. Microphysiological engineering of self-assembled and perfusable microvascular beds for the production of vascularized three-dimensional human microtissues. |
| [47] |
Manian KV, Galloway CA, Dalvi S, Emanuel AA, Mereness JA, et al. 2021. 3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degeneration. |
| [48] |
Song MJ, Quinn R, Nguyen E, Hampton C, Sharma R, et al. 2023. Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration. |
| [49] |
Saito J, Kaneko M, Ishikawa Y, Yokoyama U. 2021. Challenges and possibilities of cell-based tissue-engineered vascular grafts. |